Ikena Oncology Inc.
1.49
-0.02 (-1.32%)
At close: Jan 15, 2025, 12:02 PM

Ratios (Annual)

Discover comprehensive ratio statement breakdowns that reveal insights into revenue, expenses, and beyond.
Year FY23 FY22 FY21 FY20 FY19 FY18
PE Ratio -1.21 -1.44 -13.22 -25.92 -68.22 -28.07
PS Ratio 8.98 6.16 14.56 124.78 83.42 1.16K
PB Ratio 0.48 0.65 2.17 -11.35 -18.67 -25.03
P/FCF Ratio -1.03 -1.27 -7.27 -29.73 24.10 -96.3
P/OCF Ratio -1.03 -1.3 -7.49 -30.33 23.94 -98.83
OCF/S Ratio -8.71 -4.75 -1.94 -4.11 3.48 -11.73
Debt / Equity Ratio 0.06 0.04 0.03 -0.00 -1.28 -1.37
Quick Ratio 12.58 7.44 8.70 5.86 3.51 5.22
Current Ratio 12.58 7.44 8.70 5.86 3.51 5.22
Asset Turnover 0.05 0.09 0.13 0.05 0.16 0.05
Interest Coverage n/a -32.99 n/a n/a n/a n/a
Return on Equity (ROE) -0.4 -0.45 -0.16 0.44 0.27 0.89
Return on Assets (ROA) -0.35 -0.39 -0.14 -0.26 -0.2 -1.98
Return on Capital (ROIC) -0.42 -0.47 -0.15 -0.32 -0.3 -2.43
Dividend Yield n/a n/a n/a n/a n/a n/a
Payout Ratio n/a n/a n/a n/a n/a n/a
Gross Profit Margin 88.86% 86.98% -52.03% -387.79% -81.33% -3.84K%
Net Profit Margin -744.17% -426.6% -110.1% -481.36% -122.28% -4.13K%
Pretax Profit Margin -745.94% -440.29% -110.1% -481.36% -122.28% -4.13K%
Operating Profit Margin -823.33% -453.99% -110.18% -484.22% -134.46% -4.13K%
FCF Margin -875.08% -483.67% -200.14% -419.75% 346.19% -1.20K%
EBITDA Margin -812.19% -449.18% -108.42% -480.95% -132.69% -4.09K%